274 related articles for article (PubMed ID: 23483679)
1. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.
Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Burney S
Psychooncology; 2013 Oct; 22(10):2169-76. PubMed ID: 23483679
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with adherence to physical activity guidelines in patients with prostate cancer.
Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Oh T; Burney S
Psychooncology; 2013 Nov; 22(11):2478-86. PubMed ID: 23749430
[TBL] [Abstract][Full Text] [Related]
3. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
5. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
[TBL] [Abstract][Full Text] [Related]
6. The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: a systematic review.
Chipperfield K; Brooker J; Fletcher J; Burney S
Health Psychol; 2014 Nov; 33(11):1288-97. PubMed ID: 24245841
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
[TBL] [Abstract][Full Text] [Related]
9. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
[TBL] [Abstract][Full Text] [Related]
13. Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.
Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song H
Eur J Oncol Nurs; 2017 Oct; 30():84-90. PubMed ID: 29031319
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.
Keogh JW; Patel A; MacLeod RD; Masters J
Psychooncology; 2013 Dec; 22(12):2869-75. PubMed ID: 23904113
[TBL] [Abstract][Full Text] [Related]
16. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
[TBL] [Abstract][Full Text] [Related]
17. Information needs of men on androgen deprivation therapy.
Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
[TBL] [Abstract][Full Text] [Related]
19. Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer.
Kushnir T; Gofrit ON; Elkayam R; Paluch-Shimon S; Lawrence YR; Weiss L; Symon Z
Isr Med Assoc J; 2016 Jan; 18(1):49-53. PubMed ID: 26964281
[TBL] [Abstract][Full Text] [Related]
20. Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapy interventions.
Sharpley CF; Bitsika V; Christie DR
J Psychosoc Oncol; 2012; 30(2):185-97. PubMed ID: 22416955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]